Evidence map›Paper›PMID 39386801›Full record

ArticleHeliyon2024

CD8+ T cell associated scoring model helps prognostic diagnosis and immunotherapy selection in patients with colon adenocarcinoma.

Zheng Zhao, Mingkai Chen, Kuanxue Sun, Xinqi Gu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zheng ZhaoDeparment of General Surgery, Gongli Hospital, Pudong New Area, Shanghai, China.
Mingkai ChenDeparment of Gastroenterlogy, Zhengzhou Yihe Hospital, Zhengzhou, China.
Kuanxue SunDeparment of General Surgery, Gongli Hospital, Pudong New Area, Shanghai, China.
Xinqi GuDepartment of Gastroenterlogy, Shanghai Pudong Hospital, Pudong Medical Center of Fudan University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: T cell-mediated immunity plays a crucial role in the immune response against tumors, with CD 8+ T cells playing a leading role in the eradication of cancer cells. Material and methods: A total of 5 datasets were included in this study. Single cell transcriptome data were used to discover CD8 Result: Single-cell transcriptome data identified 65 CD8 Conclusion: Our research introduces a novel prognostic signature based on CD8

Indexed as

CD8+ T cellColon adenocarcinomaImmunotherapyMulti-omicsPrognostic signature

Identifiers

PMID39386801
PMCPMC11462492

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.